158 related articles for article (PubMed ID: 16715430)
1. Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case.
Higuchi R; Yamamoto M; Hatori T; Shimizu K; Imai K; Takasaki K
Surg Today; 2006; 36(6):559-62. PubMed ID: 16715430
[TBL] [Abstract][Full Text] [Related]
2. Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma.
Shimizu K; Kotera Y; Aruga A; Takeshita N; Takasaki K; Yamamoto M
J Hepatobiliary Pancreat Sci; 2012 Mar; 19(2):171-8. PubMed ID: 21874278
[TBL] [Abstract][Full Text] [Related]
3. A long-term survivor of intrahepatic cholangiocarcinoma with lymph node metastasis: a case report.
Yamamoto M; Takasaki K; Imaizumi T; Ariizumi S; Matsumura N; Nakano M
Jpn J Clin Oncol; 2002 Jun; 32(6):206-9. PubMed ID: 12110637
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
5. [Dendritic cell vaccine for intrahepatic cholangio cellular carcinoma--a study of relationship between immuno-reaction and clinical outcome].
Kotera Y; Kougen Y; Aruga A; Yamamoto M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1964-6. PubMed ID: 20037292
[TBL] [Abstract][Full Text] [Related]
6. [A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy].
Hayashi H; Beppu T; Ishiko T; Mizumoto T; Masuda T; Okabe K; Baba Y; Okabe H; Takamori H; Kanemitsu K; Hiroto M; Baba H
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1941-3. PubMed ID: 17212153
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA.
Junking M; Grainok J; Thepmalee C; Wongkham S; Yenchitsomanus PT
Tumour Biol; 2017 Oct; 39(10):1010428317733367. PubMed ID: 29034817
[TBL] [Abstract][Full Text] [Related]
8. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis.
Asakura H; Ohtsuka M; Ito H; Kimura F; Ambiru S; Shimizu H; Togawa A; Yoshidome H; Kato A; Miyazaki M
Hepatogastroenterology; 2005; 52(63):722-4. PubMed ID: 15966191
[TBL] [Abstract][Full Text] [Related]
10. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma.
Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Mori A; Doi R; Ikai I; Uemoto S
Surgery; 2008 Jun; 143(6):769-77. PubMed ID: 18549893
[TBL] [Abstract][Full Text] [Related]
11. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy.
Koido S; Kan S; Yoshida K; Yoshizaki S; Takakura K; Namiki Y; Tsukinaga S; Odahara S; Kajihara M; Okamoto M; Ito M; Yusa S; Gong J; Sugiyama H; Ohkusa T; Homma S; Tajiri H
Anticancer Res; 2014 Nov; 34(11):6353-61. PubMed ID: 25368235
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities.
Shirabe K; Shimada M; Harimoto N; Sugimachi K; Yamashita Y; Tsujita E; Aishima S
Surgery; 2002 Jan; 131(1 Suppl):S159-64. PubMed ID: 11821804
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H
Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.
Jiang BG; Sun LL; Yu WL; Tang ZH; Zong M; Zhang YJ
Cancer J; 2009; 15(3):257-61. PubMed ID: 19556914
[TBL] [Abstract][Full Text] [Related]
16. [A case of surgical resection of a combined hepatocellular and cholangiocarcinoma after transarterial chemoembolization].
Yakoshi Y; Toyoki Y; Ishido K; Kudo D; Kimura N; Wakiya T; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1798-800. PubMed ID: 24393926
[TBL] [Abstract][Full Text] [Related]
17. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution.
Kim DH; Choi DW; Choi SH; Heo JS; Kow AW
Surgery; 2015 Apr; 157(4):666-75. PubMed ID: 25682172
[TBL] [Abstract][Full Text] [Related]
18. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.
Uenishi T; Kubo S; Yamazaki O; Yamada T; Sasaki Y; Nagano H; Monden M
J Hepatobiliary Pancreat Surg; 2008; 15(4):417-22. PubMed ID: 18670844
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival of peripheral intrahepatic cholangiocarcinoma with distant metastasis.
Izumi R; Shimizu K; Kiriyama M; Yagi M; Matsui O; Nonomura A; Miyazaki I
Am J Gastroenterol; 1995 Mar; 90(3):505-7. PubMed ID: 7872300
[No Abstract] [Full Text] [Related]
20. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
